A citation-based method for searching scientific literature

Alessia Pellerino, Francesco Bruno, Roberta Rudà, Riccardo Soffietti. Curr Treat Options Oncol 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment.
Madhav D Sharma, Rahul Shinde, Tracy L McGaha, Lei Huang, Rikke B Holmgaard, Jedd D Wolchok, Mario R Mautino, Esteban Celis, Arlene H Sharpe, Loise M Francisco,[...]. Sci Adv 2015
111
100

Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities.
Davood Bashash, Zahra Zandi, Bahareh Kashani, Atieh Pourbagheri-Sigaroodi, Sina Salari, Seyed H Ghaffari. J Cell Physiol 2022
5
100


Cause-and-Effect relationship between FGFR1 expression and epithelial-mesenchymal transition in EGFR-mutated non-small cell lung cancer cells.
Johan Vad-Nielsen, Kristine Raaby Gammelgaard, Tina Fuglsang Daugaard, Anders Lade Nielsen. Lung Cancer 2019
12
100

Progress and perspective of microneedle system for anti-cancer drug delivery.
Dongdong Li, Doudou Hu, Hongxia Xu, Hirak K Patra, Xiangrui Liu, Zhuxian Zhou, Jianbin Tang, Nigel Slater, Youqing Shen. Biomaterials 2021
21
100

Thermo-Triggered In Situ Chitosan-Based Gelation System for Repeated and Enhanced Sonodynamic Therapy Post a Single Injection.
Jialin She, Xuanfang Zhou, Yaojia Zhang, Rui Zhang, Quguang Li, Wenju Zhu, Zhouqi Meng, Zhuang Liu. Adv Healthc Mater 2021
6
100

Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma.
Tuba N Gide, James S Wilmott, Richard A Scolyer, Georgina V Long. Clin Cancer Res 2018
175
100

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations.
Judith A Seidel, Atsushi Otsuka, Kenji Kabashima. Front Oncol 2018
536
100

Hypoxia-inducible factors in stem cells and cancer.
Jolly Mazumdar, Vijay Dondeti, M Celeste Simon. J Cell Mol Med 2009
99
100

Collateral sensitivity as a strategy against cancer multidrug resistance.
Kristen M Pluchino, Matthew D Hall, Andrew S Goldsborough, Richard Callaghan, Michael M Gottesman. Drug Resist Updat 2012
209
100

CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Yeongseon Byeon, Jeong-Won Lee, Whan Soo Choi, Ji Eun Won, Ga Hee Kim, Min Gi Kim, Tae In Wi, Jae Myeong Lee, Tae Heung Kang, In Duk Jung,[...]. Cancer Res 2018
56
100

Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
Yanli Li, Yibin Deng, Xin Tian, Hengte Ke, Miao Guo, Aijun Zhu, Tao Yang, Zhengqing Guo, Zhishen Ge, Xiangliang Yang,[...]. ACS Nano 2015
97
100

RNAi-based therapeutics and tumor targeted delivery in cancer.
Goknur Kara, George A Calin, Bulent Ozpolat. Adv Drug Deliv Rev 2022
13
100


Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer.
Ferdinandos Skoulidis, Vassiliki A Papadimitrakopoulou. Clin Cancer Res 2017
29
100

Mechanisms of immune evasion in bladder cancer.
Paul L Crispen, Sergei Kusmartsev. Cancer Immunol Immunother 2020
54
100

Recent Advancements in Microneedle Technology for Multifaceted Biomedical Applications.
Deepak Kulkarni, Fouad Damiri, Satish Rojekar, Mehrukh Zehravi, Sarker Ramproshad, Dipali Dhoke, Shubham Musale, Ashiya A Mulani, Pranav Modak, Roshani Paradhi,[...]. Pharmaceutics 2022
5
100

ABC Transporter-Mediated Multidrug-Resistant Cancer.
Haneen Amawi, Hong-May Sim, Amit K Tiwari, Suresh V Ambudkar, Suneet Shukla. Adv Exp Med Biol 2019
88
100

Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody.
Chao Wang, Yanqi Ye, Gabrielle M Hochu, Hasan Sadeghifar, Zhen Gu. Nano Lett 2016
361
100

Tumour-intrinsic resistance to immune checkpoint blockade.
Anusha Kalbasi, Antoni Ribas. Nat Rev Immunol 2020
404
100


Emerging role of PTEN loss in evasion of the immune response to tumours.
Thiago Vidotto, Camila Morais Melo, Erick Castelli, Madhuri Koti, Rodolfo Borges Dos Reis, Jeremy A Squire. Br J Cancer 2020
42
100

Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds.
Zhaowu Ma, Xiaoqiang Xiang, Shiya Li, Peng Xie, Quan Gong, Boon-Cher Goh, Lingzhi Wang. Semin Cancer Biol 2022
32
100

Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches.
Qiong Wu, Zhiping Yang, Yongzhan Nie, Yongquan Shi, Daiming Fan. Cancer Lett 2014
379
100

Nanotechnology of Tyrosine Kinase Inhibitors in Cancer Therapy: A Perspective.
Eleonora Russo, Andrea Spallarossa, Bruno Tasso, Carla Villa, Chiara Brullo. Int J Mol Sci 2021
3
100

Inhibition of hypoxia inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy.
Ruud Weijer, Mans Broekgaarden, Massis Krekorian, Lindy K Alles, Albert C van Wijk, Claire Mackaaij, Joanne Verheij, Allard C van der Wal, Thomas M van Gulik, Gert Storm,[...]. Oncotarget 2016
46
100

Active targeting strategy in nanomedicines using anti-EGFR ligands - A promising approach for cancer therapy and diagnosis.
Phuoc Vinh Nguyen, Katel Hervé-Aubert, Igor Chourpa, Emilie Allard-Vannier. Int J Pharm 2021
3
100

EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis.
Jerrica L Breindel, Jonathan W Haskins, Elizabeth P Cowell, Minghui Zhao, Don X Nguyen, David F Stern. Cancer Res 2013
87
100

A novel FGFR1-binding peptide exhibits anti-tumor effect on lung cancer by inhibiting proliferation and angiogenesis.
Qiaoyan Tan, Zuqiang Wang, Quan Wang, Yuanqiang Wang, Zhifeng Huang, Nan Su, Min Jin, Liang Kuang, Huabing Qi, Zhenhong Ni,[...]. Int J Biol Sci 2018
9
100

Clinical comparison between paclitaxel liposome (Lipusu®) and paclitaxel for treatment of patients with metastatic gastric cancer.
Xu Xu, Lin Wang, Huan-Qin Xu, Xin-En Huang, Ya-Dong Qian, Jin Xiang. Asian Pac J Cancer Prev 2013
86
100

Anticancer drug resistance: An update and perspective.
Ruth Nussinov, Chung-Jung Tsai, Hyunbum Jang. Drug Resist Updat 2021
20
100

Cytokines in cancer drug resistance: Cues to new therapeutic strategies.
Valerie Sloane Jones, Ren-Yu Huang, Li-Pai Chen, Zhe-Sheng Chen, Liwu Fu, Ruo-Pan Huang. Biochim Biophys Acta 2016
113
100

Recent progress in targeted delivery vectors based on biomimetic nanoparticles.
Li Chen, Weiqi Hong, Wenyan Ren, Ting Xu, Zhiyong Qian, Zhiyao He. Signal Transduct Target Ther 2021
27
100

Tumor acidity activated triphenylphosphonium-based mitochondrial targeting nanocarriers for overcoming drug resistance of cancer therapy.
Hui Yu, Jia-Mi Li, Kai Deng, Wei Zhou, Cai-Xia Wang, Qian Wang, Kun-Heng Li, Hong-Yang Zhao, Shi-Wen Huang. Theranostics 2019
20
100

Targeting EGFRL858R/T790M and EGFRL858R/T790M/C797S resistance mutations in NSCLC: Current developments in medicinal chemistry.
Xiaoyun Lu, Lei Yu, Zhang Zhang, Xiaomei Ren, Jeff B Smaill, Ke Ding. Med Res Rev 2018
63
100

Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma.
Manfei Pi, Huixian Kuang, Chunyan Yue, Qixuan Yang, Anqin Wu, Yuhua Li, Yehuda G Assaraf, Dong-Hua Yang, Shaojie Wu. Drug Resist Updat 2022
6
100

Reactivation of the tumor suppressor PTEN by mRNA nanoparticles enhances antitumor immunity in preclinical models.
Yao-Xin Lin, Yi Wang, Jianxun Ding, Aiping Jiang, Jie Wang, Mian Yu, Sara Blake, Shuaishuai Liu, Charles J Bieberich, Omid C Farokhzad,[...]. Sci Transl Med 2021
25
100

Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Maya Bar-Zeev, Yoav D Livney, Yehuda G Assaraf. Drug Resist Updat 2017
152
100

Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution.
Kvar C L Black, Yucai Wang, Hannah P Luehmann, Xin Cai, Wenxin Xing, Bo Pang, Yongfeng Zhao, Cathy S Cutler, Lihong V Wang, Yongjian Liu,[...]. ACS Nano 2014
179
100

Progress toward overcoming hypoxia-induced resistance to solid tumor therapy.
Sergey V Karakashev, Mauricio J Reginato. Cancer Manag Res 2015
62
100

Drug resistance and Cancer stem cells.
Yuan Li, Zhenning Wang, Jaffer A Ajani, Shumei Song. Cell Commun Signal 2021
29
100

Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
Khalil Khalaf, Doris Hana, Jadzia Tin-Tsen Chou, Chandpreet Singh, Andrzej Mackiewicz, Mariusz Kaczmarek. Front Immunol 2021
45
100


Dual-Targeted Therapy Circumvents Non-Genetic Drug Resistance to Targeted Therapy.
Wei Wang, Yue Sun, Xiaobo Liu, Shaji K Kumar, Fengyan Jin, Yun Dai. Front Oncol 2022
1
100

Reversing Multidrug Resistance by Inducing Mitochondrial Dysfunction for Enhanced Chemo-Photodynamic Therapy in Tumor.
Chao Shi, Haiqiao Huang, Xiao Zhou, Zhen Zhang, He Ma, Qichao Yao, Kun Shao, Wen Sun, Jianjun Du, Jiangli Fan,[...]. ACS Appl Mater Interfaces 2021
6
100

DNA damage response proteins synergistically affect the cancer prognosis and resistance.
Meetal Sharma, Prince Anand, Yogendra S Padwad, Vivek Dogra, Vishal Acharya. Free Radic Biol Med 2022
1
100

Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells.
Hamed Rezayatmand, Mahboobeh Razmkhah, Iman Razeghian-Jahromi. Stem Cell Res Ther 2022
2
100

Nanoarchitectonics with metal-organic frameworks and platinum nanozymes with improved oxygen evolution for enhanced sonodynamic/chemo-therapy.
Qian Ren, Nuo Yu, Leyi Wang, Mei Wen, Peng Geng, Qin Jiang, Maoquan Li, Zhigang Chen. J Colloid Interface Sci 2022
6
100


BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFRT790M mutation.
Weimin Yin, Yuge Zhao, Xuejia Kang, Pengfei Zhao, Xuhong Fu, Xiaopeng Mo, Yakun Wang, Yongzhuo Huang. Theranostics 2020
21
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.